Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $930.87 billion, total revenue of $175.3 billion and a weighted average PE ratio of 48.50.
Market Cap
930.87B
Revenue
175.3B
Profits
19.19B
PE Ratio
48.50
Profit Margin
10.95%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 253.80B | -1.72% | 875,135 | 47.35B |
| 2 | DHR | Danaher Corporation | 161.45B | -1.18% | 1,099,486 | 25.61B |
| 3 | NTRA | Natera, Inc. | 55.49B | -7.08% | 1,336,680 | 2.71B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 52.25B | 20.33% | 1,312,152 | 4.66B |
| 5 | A | Agilent Technologies, Inc. | 48.77B | -1.07% | 780,366 | 7.37B |
| 6 | WAT | Waters Corporation | 44.46B | -2.19% | 954,472 | 4.64B |
| 7 | IQV | IQVIA Holdings Inc. | 43.14B | -2.08% | 589,769 | 17.31B |
| 8 | ILMN | Illumina, Inc. | 34.59B | -3.06% | 1,632,319 | 4.54B |
| 9 | MTD | Mettler-Toledo International Inc. | 33.54B | -0.05% | 86,002 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 28.95B | -1.35% | 589,824 | 14.59B |
| 11 | DGX | Quest Diagnostics Incorporated | 27.50B | -0.73% | 343,121 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 23.05B | -3.95% | 1,176,290 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.23B | -0.03% | 92,300 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 17.03B | -2.79% | 1,405,585 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 16.36B | -4.64% | 742,728 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 15.42B | -2.63% | 397,187 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.41B | 0.24% | 2,313,390 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.02B | -5.98% | 459,296 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.86B | 1.25% | 355,238 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.12B | -1.10% | 1,048,850 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 5.12B | -4.34% | 315,671 | 397.41M |
| 22 | CDNA | CareDx, Inc. | 4.53B | -1.27% | 1,129,835 | 497.40M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 4.00B | -5.89% | 988,786 | 308.08M |
| 24 | VCYT | Veracyte, Inc. | 3.96B | -1.44% | 378,674 | 561.90M |
| 25 | NEO | NeoGenomics, Inc. | 2.16B | -3.94% | 616,710 | 787.75M |
| 26 | WGS | GeneDx Holdings Corp. | 1.94B | -5.85% | 184,835 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.69B | 0.09% | 867,961 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.27B | -5.61% | 335,992 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.26B | 1.81% | 1,728,000 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.08B | -5.23% | 289,095 | 357.28M |
| 31 | MYGN | Myriad Genetics, Inc. | 560.51M | -7.72% | 521,624 | 806.60M |
| 32 | FLGT | Fulgent Genetics, Inc. | 533.25M | -6.01% | 145,613 | 323.93M |
| 33 | BDSX | Biodesix, Inc. | 229.53M | -6.46% | 32,697 | 102.94M |
| 34 | XGN | Exagen Inc. | 202.64M | -2.62% | 75,534 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 107.36M | -6.61% | 8,881 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 93.26M | -3.72% | 45,011 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 65.35M | -7.45% | 236,447 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 32.55M | 0.44% | 9,617 | 27.20M |
| 39 | MDXH | MDxHealth SA | 15.08M | -3.25% | 443,150 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.11M | -0.21% | 3,090 | - |
| 41 | XWEL | XWELL, Inc. | 6.21M | 4.74% | 11,902 | 28.28M |
| 42 | BIAF | bioAffinity Technologies, Inc. | 3.82M | 2.41% | 59,728 | 5.90M |
| 43 | ADVB | Advanced Biomed Inc. | 3.52M | -7.39% | 6,277 | 127.64K |
| 44 | ISPC | iSpecimen Inc. | 2.06M | -0.71% | 26,424 | 466.30K |